Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
PRGO is in an Uptrend called by SmarTrend on August 11, 2011 at $86.82. With a price of $96.72 in late September 2011, this stock increased 11.4% since SmarTrend’s Uptrend Alert was issued. Watson Pharmaceuticals, Inc. (WPI), a …
Perrigo Company plc PRGO is expected to report first-quarter 2017 results later ... that Perrigo is likely to beat earnings estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 …
One lingering legacy of the Great Recession and the "new normal" has been the rush of consumers towards private label goods. As the global crisis has hit consumers on both sides of the pond, worldwide demand for store brands has …
Perrigo (PRGO) is rising 1.2% after Argus upgraded it to Buy. Ciena (CIEN) is down 1.3% on a downgrade to Neutral from Piper Jaffray.
June 14 (Reuters) - Perrigo Company Plc ::Perrigo company plc announces pricing for its cash tender offer.Announced reference yield & total consideration for up to principal amount of $1.40 billion of co's 4.000% notes due 2023 and …
Last month, Minnesota-based medical-device maker Medtronic acquired Covidien in a $42.9 billion cash and stock deal that will allow the company to move its tax base to Ireland. Earlier this spring, AstraZeneca rejected Pfizer's takeover …
Perrigo Co Plc (NASDAQ:PRGO) traded in a range yesterday that spanned from a low of $75.58 to a high of $77.74. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $75.50 on volume of 944,000 …
The US drug development company has a market cap of $1.43 billion. The Tel Aviv Stock Exchange (TASE) has approved the dual-listing of US drug development company MannKind Corporation (NASDAQ: MNKD). Based in …